Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Plos One|October 12, 2012
AZD1480 blocks growth and tumorigenesis of RET- activated thyroid cancer cell linesJoana P Couto, Ana Almeida, Laura Daly, et al.Journal of Thyroid Research|July 19, 2011
How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid CancerHugo Prazeres, Joana Torres, Fernando Rodrigues, et al.Journal of Thyroid Research|July 20, 2016
Corrigendum to "How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer"Hugo Prazeres, Joana Torres, Fernando Rodrigues, et al.Endocrine-Related Cancer|May 10, 2011
In vitro transforming potential, intracellular signaling properties, and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu, and Arg886TrpHugo Prazeres, Joana P Couto, Fernando Rodrigues, et al.Current Genomics|June 2, 2012
Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomasPaula Soares, Jorge Lima, Ana Preto, et al.The Journal of Clinical Endocrinology and Metabolism|May 3, 2012
mTOR pathway overactivation in BRAF mutated papillary thyroid carcinomaAlexandra Faustino, Joana P Couto, Helena Pópulo, et al.Pageof 1